Journal of Experimental Medicine, Vol 183, 1965-1971, Copyright © 1996 by Rockefeller University Press

ARTICLES

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

SL Topalian, MI Gonzales, M Parkhurst, YF Li, S Southwood, A Sette, SA Rosenberg and PF Robbins
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Tyrosinase was the first melanoma-associated antigen shown to be recognized by CD4+ T cells. In this study, we have identified two HLA- DRB1*0401-restricted peptides recognized by these T cells: Ty 56-70 and Ty 448-462. As with many of the MHC class I-restricted melanoma epitopes, both are nonmutated self peptides that have intermediate and weak MHC binding affinities, respectively. Mutated and truncated versions of these peptides were used to define their MHC binding anchor residues. Anchor residues were then modified to derive peptides with increased MHC binding affinities and T cell stimulatory properties. Ty 56-70 and Ty 448-462 enhance the list of immunogenic HLA-A2-, A24-, and B44-restricted tyrosinase peptides already described. Thus, tyrosinase provides a model for anti-melanoma vaccines in which a single molecule can generate multivalent immunization incorporating both CD4+ and CD8+ T cell responses.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Dalai, S. K., Mirshahidi, S., Morrot, A., Zavala, F., Sadegh-Nasseri, S. (2008). Anergy in Memory CD4+ T Cells Is Induced by B Cells. J. Immunol. 181: 3221-3231 [Abstract] [Full Text]  
• Caserta, S., Alessi, P., Guarnerio, J., Basso, V., Mondino, A. (2008). Synthetic CD4+ T Cell-Targeted Antigen-Presenting Cells Elicit Protective Antitumor Responses. Cancer Res. 68: 3010-3018 [Abstract] [Full Text]  
• Lizee, G., Cantu, M. A., Hwu, P. (2007). Less Yin, More Yang: Confronting the Barriers to Cancer Immunotherapy. Clin. Cancer Res. 13: 5250-5255 [Abstract] [Full Text]  
• Sugita, S., Takase, H., Taguchi, C., Imai, Y., Kamoi, K., Kawaguchi, T., Sugamoto, Y., Futagami, Y., Itoh, K., Mochizuki, M. (2006). Ocular Infiltrating CD4+ T Cells from Patients with Vogt-Koyanagi-Harada Disease Recognize Human Melanocyte Antigens.. IOVS 47: 2547-2554 [Abstract] [Full Text]  
• Lindsey, K. R., Gritz, L., Sherry, R., Abati, A., Fetsch, P. A., Goldfeder, L. C., Gonzales, M. I., Zinnack, K. A., Rogers-Freezer, L., Haworth, L., Mavroukakis, S. A., White, D. E., Steinberg, S. M., Restifo, N. P., Panicali, D. L., Rosenberg, S. A., Topalian, S. L. (2006). Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma. Clin. Cancer Res. 12: 2526-2537 [Abstract] [Full Text]  
• Lucchese, A., Willers, J., Mittelman, A., Kanduc, D., Dummer, R. (2005). Proteomic Scan for Tyrosinase Peptide Antigenic Pattern in Vitiligo and Melanoma: Role of Sequence Similarity and HLA-DR1 Affinity. J. Immunol. 175: 7009-7020 [Abstract] [Full Text]  
• Neumann, F., Wagner, C., Preuss, K.-D., Kubuschok, B., Schormann, C., Stevanovic, S., Pfreundschuh, M. (2005). Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells. Blood 106: 3105-3113 [Abstract] [Full Text]  
• de Vries, I. J. M., Bernsen, M. R., Lesterhuis, W. J., Scharenborg, N. M., Strijk, S. P., Gerritsen, M.-J. P., Ruiter, D. J., Figdor, C. G., Punt, C. J.A., Adema, G. J. (2005). Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome. JCO 23: 5779-5787 [Abstract] [Full Text]  
• Dengjel, J., Schoor, O., Fischer, R., Reich, M., Kraus, M., Muller, M., Kreymborg, K., Altenberend, F., Brandenburg, J., Kalbacher, H., Brock, R., Driessen, C., Rammensee, H.-G., Stevanovic, S. (2005). From the Cover: Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl. Acad. Sci. USA 102: 7922-7927 [Abstract] [Full Text]  
• Bonehill, A., Heirman, C., Tuyaerts, S., Michiels, A., Breckpot, K., Brasseur, F., Zhang, Y., van der Bruggen, P., Thielemans, K. (2004). Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules. J. Immunol. 172: 6649-6657 [Abstract] [Full Text]  
• Danke, N. A., Koelle, D. M., Yee, C., Beheray, S., Kwok, W. W. (2004). Autoreactive T Cells in Healthy Individuals. J. Immunol. 172: 5967-5972 [Abstract] [Full Text]  
• Maccalli, C., Li, Y. F., El-Gamil, M., Rosenberg, S. A., Robbins, P. F. (2003). Identification of a Colorectal Tumor-Associated Antigen (COA-1) Recognized by CD4+ T Lymphocytes. Cancer Res. 63: 6735-6743 [Abstract] [Full Text]  
• Tatsumi, T., Herrem, C. J., Olson, W. C., Finke, J. H., Bukowski, R. M., Kinch, M. S., Ranieri, E., Storkus, W. J. (2003). Disease Stage Variation in CD4+ and CD8+ T-Cell Reactivity to the Receptor Tyrosine Kinase EphA2 in Patients with Renal Cell Carcinoma. Cancer Res. 63: 4481-4489 [Abstract] [Full Text]  
• Schroers, R., Shen, L., Rollins, L., Xiao, Z., Sonderstrup, G., Slawin, K., Huang, X. F., Chen, S.-Y. (2003). Identification of MHC Class II-restricted T-cell Epitopes in Prostate-specific Membrane Antigen. Clin. Cancer Res. 9: 3260-3271 [Abstract] [Full Text]  
• Davila, E., Kennedy, R., Celis, E. (2003). Generation of Antitumor Immunity by Cytotoxic T Lymphocyte Epitope Peptide Vaccination, CpG-oligodeoxynucleotide Adjuvant, and CTLA-4 Blockade. Cancer Res. 63: 3281-3288 [Abstract] [Full Text]  
• Novellino, L., Renkvist, N., Rini, F., Mazzocchi, A., Rivoltini, L., Greco, A., Deho, P., Squarcina, P., Robbins, P. F., Parmiani, G., Castelli, C. (2003). Identification of a Mutated Receptor-Like Protein Tyrosine Phosphatase {kappa} as a Novel, Class II HLA-Restricted Melanoma Antigen. J. Immunol. 170: 6363-6370 [Abstract] [Full Text]  
• Robbins, P. F., El-Gamil, M., Li, Y. F., Zeng, G., Dudley, M., Rosenberg, S. A. (2002). Multiple HLA Class II-Restricted Melanocyte Differentiation Antigens Are Recognized by Tumor-Infiltrating Lymphocytes from a Patient with Melanoma. J. Immunol. 169: 6036-6047 [Abstract] [Full Text]  
• Topalian, S. L., Gonzales, M. I., Ward, Y., Wang, X., Wang, R.-F. (2002). Revelation of a Cryptic Major Histocompatibility Complex Class II-restricted Tumor Epitope in a Novel RNA-processing Enzyme. Cancer Res. 62: 5505-5509 [Abstract] [Full Text]  
• Kobayashi, H., Omiya, R., Ruiz, M., Huarte, E., Sarobe, P., Lasarte, J. J., Herraiz, M., Sangro, B., Prieto, J., Borras-Cuesta, F., Celis, E. (2002). Identification of an Antigenic Epitope for Helper T Lymphocytes from Carcinoembryonic Antigen. Clin. Cancer Res. 8: 3219-3225 [Abstract] [Full Text]  
• Wang, H. Y., Zhou, J., Zhu, K., Riker, A. I., Marincola, F. M., Wang, R.-F. (2002). Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4+T Cells: Its Role in Extracellular Matrix Formation and Tumor Metastasis. J. Exp. Med. 195: 1397-1406 [Abstract] [Full Text]  
• Haque, M. A., Li, P., Jackson, S. K., Zarour, H. M., Hawes, J. W., Phan, U. T., Maric, M., Cresswell, P., Blum, J. S. (2002). Absence of {gamma}-Interferon-inducible Lysosomal Thiol Reductase in Melanomas Disrupts T Cell Recognition of Select Immunodominant Epitopes. J. Exp. Med. 195: 1267-1277 [Abstract] [Full Text]  
• Schuler-Thurner, B., Schultz, E. S., Berger, T. G., Weinlich, G., Ebner, S., Woerl, P., Bender, A., Feuerstein, B., Fritsch, P. O., Romani, N., Schuler, G. (2002). Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells. J. Exp. Med. 195: 1279-1288 [Abstract] [Full Text]  
• Halaban, R., Patton, R. S., Cheng, E., Svedine, S., Trombetta, E. S., Wahl, M. L., Ariyan, S., Hebert, D. N. (2002). Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway. J. Biol. Chem. 277: 14821-14828 [Abstract] [Full Text]  
• Sosman, J. A., Unger, J. M., Liu, P.-Y., Flaherty, L. E., Park, M. S., Kempf, R. A., Thompson, J. A., Terasaki, P. I., Sondak, V. K. (2002). Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Impact of HLA Class I Antigen Expression on Outcome. JCO 20: 2067-2075 [Abstract] [Full Text]  
• Kobayashi, H., Lu, J., Celis, E. (2001). Identification of Helper T-Cell Epitopes That Encompass or Lie Proximal to Cytotoxic T-Cell Epitopes in the gp100 Melanoma Tumor Antigen. Cancer Res. 61: 7577-7584 [Abstract] [Full Text]  
• Mirshahidi, S., Huang, C.-T., Sadegh-Nasseri, S. (2001). Anergy in Peripheral Memory CD4+ T Cells Induced by Low Avidity Engagement of T Cell Receptor. J. Exp. Med. 194: 719-732 [Abstract] [Full Text]  
• Keogh, E., Fikes, J., Southwood, S., Celis, E., Chesnut, R., Sette, A. (2001). Identification of New Epitopes from Four Different Tumor-Associated Antigens: Recognition of Naturally Processed Epitopes Correlates with HLA-A*0201-Binding Affinity. J. Immunol. 167: 787-796 [Abstract] [Full Text]  
• McNeel, D. G., Nguyen, L. D., Disis, M. L. (2001). Identification of T Helper Epitopes from Prostatic Acid Phosphatase. Cancer Res. 61: 5161-5167 [Abstract] [Full Text]  
• Deffrennes, V., Vedrenne, J., Stolzenberg, M.-C., Piskurich, J., Barbieri, G., Ting, J. P., Charron, D., Alcaide-Loridan, C. (2001). Constitutive Expression of MHC Class II Genes in Melanoma Cell Lines Results from the Transcription of Class II Transactivator Abnormally Initiated from Its B Cell-Specific Promoter. J. Immunol. 167: 98-106 [Abstract] [Full Text]  
• Matsutake, T., Srivastava, P. K. (2001). The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein. Proc. Natl. Acad. Sci. USA 98: 3992-3997 [Abstract] [Full Text]  
• Zeng, G., Wang, X., Robbins, P. F., Rosenberg, S. A., Wang, R.-F. (2001). CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production. Proc. Natl. Acad. Sci. USA 10.1073/pnas.061507398v1 [Abstract] [Full Text]  
• Chiari, R., Hames, G., Stroobant, V., Texier, C., Maillère, B., Boon, T., Coulie, P. G. (2000). Identification of a Tumor-specific Shared Antigen Derived From an Eph Receptor and Presented to CD4 T Cells on HLA Class II Molecules. Cancer Res. 60: 4855-4863 [Abstract] [Full Text]  
• Zarour, H. M., Storkus, W. J., Brusic, V., Williams, E., Kirkwood, J. M. (2000). NY-ESO-1 Encodes DRB1*0401-restricted Epitopes Recognized by Melanoma-reactive CD4+ T Cells. Cancer Res. 60: 4946-4952 [Abstract] [Full Text]  
• Zeng, G., Touloukian, C. E., Wang, X., Restifo, N. P., Rosenberg, S. A., Wang, R.-F. (2000). Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules. J. Immunol. 165: 1153-1159 [Abstract] [Full Text]  
• Franke, E. D., Sette, A., Sacci, J. Jr., Southwood, S., Corradin, G., Hoffman, S. L. (2000). A Subdominant CD8+ Cytotoxic T Lymphocyte (CTL) Epitope from the Plasmodium yoelii Circumsporozoite Protein Induces CTLs That Eliminate Infected Hepatocytes from Culture. Infect. Immun. 68: 3403-3411 [Abstract] [Full Text]  
• Berson, J. F., Frank, D. W., Calvo, P. A., Bieler, B. M., Marks, M. S. (2000). A Common Temperature-sensitive Allelic Form of Human Tyrosinase Is Retained in the Endoplasmic Reticulum at the Nonpermissive Temperature. J. Biol. Chem. 275: 12281-12289 [Abstract] [Full Text]  
• Touloukian, C. E., Leitner, W. W., Topalian, S. L., Li, Y. F., Robbins, P. F., Rosenberg, S. A., Restifo, N. P. (2000). Identification of a MHC Class II-Restricted Human gp100 Epitope Using DR4-IE Transgenic Mice. J. Immunol. 164: 3535-3542 [Abstract] [Full Text]  
• Baxevanis, C. N., Voutsas, I. F., Tsitsilonis, O. E., Gritzapis, A. D., Sotiriadou, R., Papamichail, M. (2000). Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor. J. Immunol. 164: 3902-3912 [Abstract] [Full Text]  
• Gajewski, T. F. (2000). Monitoring Specific T-Cell Responses to Melanoma Vaccines: ELISPOT, Tetramers, and Beyond. CVI 7: 141-144 [Full Text]  
• Stenner-Liewen, F., Luo, G., Sahin, U., Tureci, O., Koslovski, M., Kautz, I., Liewen, H., Pfreundschuh, M. (2000). Definition of Tumor-associated Antigens in Hepatocellular Carcinoma. Cancer Epidemiol. Biomarkers Prev. 9: 285-290 [Abstract] [Full Text]  
• Jager, E., Jager, D., Karbach, J., Chen, Y.-T., Ritter, G., Nagata, Y., Gnjatic, S., Stockert, E., Arand, M., Old, L. J., Knuth, A. (2000). Identification of NY-ESO-1 Epitopes Presented by Human Histocompatibility Antigen (HLA)-DRB4*0101-0103 and Recognized by CD4+ T Lymphocytes of Patients with NY-ESO-1-expressing Melanoma. J. Exp. Med. 191: 625-630 [Abstract] [Full Text]  
• Falk, K., Rotzschke, O., Santambrogio, L., Dorf, M. E., Brosnan, C., Strominger, J. L. (2000). Induction and Suppression of an Autoimmune Disease by Oligomerized T Cell Epitopes: Enhanced In Vivo Potency of Encephalitogenic Peptides. J. Exp. Med. 191: 717-730 [Abstract] [Full Text]  
• Oka, Y., Udaka, K., Tsuboi, A., Elisseeva, O. A., Ogawa, H., Aozasa, K., Kishimoto, T., Sugiyama, H. (2000). Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product. J. Immunol. 164: 1873-1880 [Abstract] [Full Text]  
• Zarour, H. M., Kirkwood, J. M., Kierstead, L. S., Herr, W., Brusic, V., Slingluff, C. L. Jr., Sidney, J., Sette, A., Storkus, W. J. (2000). Melan-A/MART-151-73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells. Proc. Natl. Acad. Sci. USA 97: 400-405 [Abstract] [Full Text]  
• Thurner, B., Haendle, I., Roder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., Brocker, E. B., Steinman, R. M., Enk, A., Kampgen, E., Schuler, G. (1999). Vaccination with Mage-3A1 Peptide-pulsed Mature, Monocyte-derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma. J. Exp. Med. 190: 1669-1678 [Abstract] [Full Text]  
• Wang, S., Bartido, S., Yang, G., Qin, J., Moroi, Y., Panageas, K. S., Lewis, J. J., Houghton, A. N. (1999). A Role for a Melanosome Transport Signal in Accessing the MHC Class II Presentation Pathway and in Eliciting CD4+ T Cell Responses. J. Immunol. 163: 5820-5826 [Abstract] [Full Text]  
• Hohn, H., Pilch, H., Gunzel, S., Neukirch, C., Hilmes, C., Kaufmann, A., Seliger, B., Maeurer, M. J. (1999). CD4+ Tumor-Infiltrating Lymphocytes in Cervical Cancer Recognize HLA-DR-Restricted Peptides Provided by Human Papillomavirus-E7. J. Immunol. 163: 5715-5722 [Abstract] [Full Text]  
• Perrin, G., Schnuriger, V., Quiquerez, A.-L., Saas, P., Pannetier, C., de Tribolet, N., Tiercy, J.-M., Aubry, J.-P., Dietrich, P.-Y., Walker, P. R. (1999). Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset. Int Immunol 11: 1337-1350 [Abstract] [Full Text]  
• Wang, R., Wang, X., Atwood, A. C., Topalian, S. L., Rosenberg, S. A. (1999). Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen. Science 284: 1351-1354 [Abstract] [Full Text]  
• Wang, R.-F., Wang, X., Rosenberg, S. A. (1999). Identification of a Novel Major Histocompatibility Complex Class II-restricted Tumor Antigen Resulting from a Chromosomal Rearrangement Recognized by CD4+ T Cells. J. Exp. Med. 189: 1659-1668 [Abstract] [Full Text]  
• Pardoll, D. M. (1999). Inducing autoimmune disease to treat cancer. Proc. Natl. Acad. Sci. USA 96: 5340-5342 [Full Text]  
• Toes, R. E.M., Ossendorp, F., Offringa, R., Melief, C. J.M. (1999). CD4 T Cells and Their Role in Antitumor Immune Responses. J. Exp. Med. 189: 753-756 [Full Text]  
• Pieper, R., Christian, R. E., Gonzales, M. I., Nishimura, M. I., Gupta, G., Settlage, R. E., Shabanowitz, J., Rosenberg, S. A., Hunt, D. F., Topalian, S. L. (1999). Biochemical Identification of a Mutated Human Melanoma Antigen Recognized by CD4+ T Cells. J. Exp. Med. 189: 757-766 [Abstract] [Full Text]  
• Chaux, P., Vantomme, V., Stroobant, V., Thielemans, K., Corthals, J., Luiten, R., Eggermont, A. M.M., Boon, T., van der Bruggen, P. (1999). Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes. J. Exp. Med. 189: 767-778 [Abstract] [Full Text]  
• Manici, S., Sturniolo, T., Imro, M. A., Hammer, J., Sinigaglia, F., Noppen, C., Spagnoli, G., Mazzi, B., Bellone, M., Dellabona, P., Protti, M. P. (1999). Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11. J. Exp. Med. 189: 871-876 [Abstract] [Full Text]  
• Kawakami, Y., Robbins, P. F., Wang, X., Tupesis, J. P., Parkhurst, M. R., Kang, X., Sakaguchi, K., Appella, E., Rosenberg, S. A. (1998). Identification of New Melanoma Epitopes on Melanosomal Proteins Recognized by Tumor Infiltrating T Lymphocytes Restricted by HLA-A1, -A2, and -A3 Alleles. J. Immunol. 161: 6985-6992 [Abstract] [Full Text]  
• Tempero, R. M., VanLith, M. L., Morikane, K., Rowse, G. J., Gendler, S. J., Hollingsworth, M. A. (1998). CD4+ Lymphocytes Provide MUC1-Specific Tumor Immunity In Vivo That Is Undetectable In Vitro and Is Absent in MUC1 Transgenic Mice. J. Immunol. 161: 5500-5506 [Abstract] [Full Text]  
• Dyall, R., Bowne, W. B., Weber, L. W., LeMaoult, J., Szabo, P., Moroi, Y., Piskun, G., Lewis, J. J., Houghton, A. N., Nikolic-Zugic, J. (1998). Heteroclitic Immunization Induces Tumor Immunity. J. Exp. Med. 188: 1553-1561 [Abstract] [Full Text]  
• Correale, P., Walmsley, K., Zaremba, S., Zhu, M., Schlom, J., Tsang, K. Y. (1998). Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide. J. Immunol. 161: 3186-3194 [Abstract] [Full Text]  
• Tuting, T., Wilson, C. C., Martin, D. M., Kasamon, Y. L., Rowles, J., Ma, D. I., Slingluff, C. L. Jr., Wagner, S. N., van der Bruggen, P., Baar, J., Lotze, M. T., Storkus, W. J. (1998). Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Responses In Vitro: Enhancement by Cotransfection of Genes Encoding the Th1-Biasing Cytokines IL-12 and IFN-{alpha}. J. Immunol. 160: 1139-1147 [Abstract] [Full Text]  
• Rotzschke, O., Falk, K., Strominger, J. L. (1997). Superactivation of an immune response triggered by oligomerized T cell epitopes. Proc. Natl. Acad. Sci. USA 94: 14642-14647 [Abstract] [Full Text]  
• Osanto, S. (1997). Vaccine Trials for the Clinician: Prospects for Tumor Antigens. The Oncologist 2: 284-299 [Abstract] [Full Text]  
• Halaban, R., Cheng, E., Svedine, S., Aron, R., Hebert, D. N. (2001). Proper Folding and Endoplasmic Reticulum to Golgi Transport of Tyrosinase Are Induced by Its Substrates, DOPA and Tyrosine. J. Biol. Chem. 276: 11933-11938 [Abstract] [Full Text]  
• Zeng, G., Wang, X., Robbins, P. F., Rosenberg, S. A., Wang, R.-F. (2001). CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production. Proc. Natl. Acad. Sci. USA 98: 3964-3969 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS